Clover Health Investments (CLOV) Treasury Shares (2019 - 2026)

Clover Health Investments' Treasury Shares history runs 6 years deep, the most recent figure standing at $94.1 million for Q1 2026.

• Quarterly Treasury Shares rose 49.46% year-over-year to $94.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.1 million (up 49.46% YoY) and the FY2025 annual result came in at $86.2 million, up 178.1% from the prior year.
• Treasury Shares was $94.1 million for Q1 2026 at Clover Health Investments, up from $86.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $43.0 million in Q4 2025 and bottomed at $1.9 million in Q1 2022.
• A 5-year average of $17.2 million and a median of $14.6 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 4327.89% — and 2026, when it jumped 49.46%.
• Clover Health Investments' Treasury Shares stood at $6.5 million in 2022, then soared by 95.56% to $12.7 million in 2023, then surged by 143.47% to $31.0 million in 2024, then soared by 178.1% to $86.2 million in 2025, then grew by 9.16% to $94.1 million in 2026.
• Business Quant data shows CLOV's Treasury Shares at $94.1 million in Q1 2026, $86.2 million in Q4 2025, and $77.0 million in Q3 2025.